Skip to content

The effect of lidocaine spray and vapocolant spray in reducing the pain of venous catheterization

A comparison between the effectiveness and safety of the combination of Licodain spray and vapocolant spray, and Licodain spray alone in local anesthesia during iv catheterization

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200707048047N3
Enrollment
116
Registered
2023-03-01
Start date
2023-02-05
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduce the pain of iv catheterization.

Interventions

Intervention 1: Intervention group 1: intervention with lidocaine spray along with Deltazax Power Ice cooling spray, for this group, 10 puffs equivalent to 100 mg of 10% lidocaine solution (manufactur

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Willingness and informed consent to participate in the study Age above 18 years Alert and able to communicate No history of psychiatric disorders Do not use any topical medication Do not take painkillers for 12 hours before venipuncture Willingness and informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Lack of consent to enter the study Addiction to opioids Addiction to strong painkillers History of allergy to any of the drugs used Sensitivity to cold A history of panic attacks Patients with peripheral vascular diseases Patients with sensory disorders such as peripheral neuropathy Unwillingness to continue participating in the study

Design outcomes

Primary

MeasureTime frame
Pain intensity during venipuncture. Timepoint: Immediately after venipuncture. Method of measurement: visual analog scale (VAS), 0-3 is mild pain, 4-6 is moderate pain, and 7-10 is severe pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Moallm

Islamic Azad University

masoumehmoallem@gmail.com+98 21 2222 3567

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026